Quarterly report pursuant to Section 13 or 15(d)

SHARE-BASED COMPENSATION AND WARRANTS

v3.22.1
SHARE-BASED COMPENSATION AND WARRANTS
9 Months Ended
Mar. 31, 2022
SHARE-BASED COMPENSATION AND WARRANTS  
SHARE-BASED COMPENSATION AND WARRANTS

NOTE 7 — SHARE-BASED COMPENSATION AND WARRANTS

Stock Option Plans

Presented below is a summary of the number of shares authorized, outstanding, and available for future grants under each of the Company’s stock option plans as of March 31, 2022 (in thousands):

    

Plan Termination

    

Number of Shares

Description

    

Date

    

Authorized

    

Outstanding

    

Available

2015 Plan

 

February 2020

 

45

 

45

 

2016 Plan

 

October 2021

 

260

 

260

 

2019 Plan

 

July 2029

 

200

 

200

 

2021 Plan

March 2030

1,200

1,082

118

Total

 

  

 

1,705

 

1,587

 

118

Stock Options Outstanding

The following table sets forth a summary of the activity under all of the Company’s stock option plans for the nine months ended March 31, 2022 (shares in thousands):

    

Shares

    

Price (1)

    

Term (2)

Outstanding, June 30, 2021

 

1,285

$

16.35

 

8.7

Granted

421

5.37

Expired

(61)

20.19

Forfeited

(58)

10.28

Outstanding, March 31, 2022

 

1,587

 

13.41

 

8.6

Vested, March 31, 2022

 

620

 

19.23

 

7.5

(1) Represents the weighted average exercise price.
(2) Represents the weighted average remaining contractual term for the number of years until the stock options expire.

For the nine months ended March 31, 2022, the aggregate fair value of stock options granted for approximately 0.4 million shares of common stock that provide solely for time-based vesting, amounted to $1.7 million or approximately $4.09 per share as of the grant dates. Fair value was computed using the BSM option-pricing model and will result in the recognition of compensation cost ratably over the expected vesting period of the stock options. For the nine months ended March 31, 2022, the fair value of stock options was estimated on the date of grant, with the following weighted-average assumptions:

Market price of common stock on grant date

$

4.09

Expected volatility

    

94

%

Risk free interest rate

 

1.8

%

Expected term (years)

 

6.1

Dividend yield

 

0

%

Share-based compensation expense for the three and nine months ended March 31, 2022 and 2021 is included under the following captions in the unaudited condensed consolidated statements of operations (in thousands):

    

Three Months Ended

Nine Months Ended

March 31, 

March 31, 

    

2022

    

2021

2022

    

2021

Research and development

$

327

$

284

$

1,014

$

1,098

General and administrative

 

523

 

246

 

1,687

 

1,207

Total

$

850

$

530

$

2,701

$

2,305

Unrecognized share-based compensation expense is approximately $6.8 million as of March 31, 2022. This amount is expected to be recognized over a weighted average period of 3.0 years.

Warrants

In connection with the 2021 Underwritten Offering discussed in Note 6, the Company issued 1,661,461 2021 PFWs to purchase 1,661,461 shares of common stock at an issuance price of $6.49 per warrant for gross proceeds of $10.8 million. The 2021 PFWs may be exercised at any time by paying the exercise price of $0.01 per share, subject to the terms discussed in Note 6.

In addition, the Company has issued warrants in conjunction with various debt and equity financings and for services. The following table sets forth a summary of the warrant activity (excluding the 2021 PFWs) for the nine months ended March 31, 2022 (shares in thousands):

    

Shares

    

Price (1)

    

Term (2)

Outstanding, beginning of period

 

1,252

  

$

28.91

 

4.8

Warrant expirations

 

(94)

  

 

95.79

 

  

Outstanding, end of period

 

1,158

  

 

23.45

 

4.4

(1) Represents the weighted average exercise price.
(2) Represents the weighted average remaining contractual term for the number of years until the warrants expire.